Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Despite its growing popularity, the clinical efficacy and safety of BPC-157 remain unproven, raising significant ethical and legal concerns
The increased BPC-157 content provides researchers with an expanded formulation for protocol flexibility, comparative studies, and extended experimental workflows
Is it safe for long-term use
In preclinical research environments, the individual components of REGENO Cartalax + TB-500 + BPC-157 have been studied for their interaction with nitric oxide-associated pathways, angiogenic signaling networks, cytoskeletal organization mechanisms, extracellular matrix-associated processes, and chondrocyte-related signaling systems
References: National Institutes of Health, Office of Dietary Supplements
